Interventional Cardiology And Peripheral Vascular Devices Market 2020-2026; Growth Forecast & Industry Share Report

1
Interventional Cardiology And Peripheral Vascular
Devices Market Growth Industry Analysis Report,
2020-2026
2
Continued

• One of the most popular players of the global
  interventional cardiology and peripheral vascular
  devices market has made it to the news headlines
  recently. Intact Vascular, Inc., a pioneer in
  medical device production for facilitating
  minimally invasive peripheral vascular trials,
  has launched the FDA-approved Tack Endovascular
  System. As per news reports, the company, in
  mid-2020 announced first commercial use of its
  Track Endovascular System across sites in the
  United States.
• The implants are designed to optimize balloon
  angioplasty outcomes in the critical limb
  ischemia patient pool across the region. In fact,
  the country holds a record of more than 4 lakh
  percutaneous coronary surgeries being performed.
  These factors have indeed, have produced a demand
  spurt for interventional cardiology and
  peripheral vascular devices.

3
Key Insights Interventional Cardiology And
Peripheral Vascular Devices Market

• Not to mention, technological advancements and
  ongoing RD efforts in the field are also likely
  to propel the global market trends over the span
  of 2020 to 2026. It has been pre-assumed that the
  worldwide interventional cardiology and
  peripheral vascular devices market would record
  phenomenal gains by the end of 2026, driven by
  its overall expansion in vivid segments including
  product, application, end-use, and
  diversification.
• Speaking of the applications, interventional
  cardiology and peripheral vascular devices are
  largely used in valvuloplasty, which helps in
  narrowing pulmonary and mitral valves. In fact, a
  statistical rise in valvular diseases is also
  touted to enhance the product deployment. As a
  matter of fact, CDC report suggests that nearly
  13 per cent of global population suffers from
  valvular heart disease, and this count is
  expected to have an immense impact on
  interventional cardiology and peripheral vascular
  devices market, as the industry had held a
  segmental share of USD 1.5 billion in 2019.

4

Latest Research Interventional Cardiology And
Peripheral Vascular Devices Market _at_
https//bit.ly/2Ux4GAe Request for a Sample
Copy of This Research Report _at_ https//bit.ly/3kN
ijGh
5
Major Companies Interventional Cardiology And
Peripheral Vascular Devices Market

• Medtronic plc
• Cardinal Health
• C.R. Bard (Becton Dickinson and Company)
• B. Braun Melsungen AG

6
Regional Interventional Cardiology And Peripheral
Vascular Devices Market

• Regionally, interventional cardiology and
  peripheral vascular devices industry is
  diversified into some major regions including
  North America, Europe, and Asia Pacific. Of
  these, the growth predominantly comes from North
  America, which is all set to emerge as a growth
  hub for the industry in the years to come. In
  fact, it was seen that the regional
  interventional cardiology and peripheral vascular
  devices market accounted for a business share of
  USD 5 billion in 2019 and is further anticipated
  to amass considerable gains over the forthcoming
  years. Thanks to the feasibility of advanced
  coronary artery disease treatment in the region.

7
Stay In Touch Social Media